Filing Details
- Accession Number:
- 0001415889-25-019433
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-07 17:31:13
- Reporting Period:
- 2025-07-07
- Filing Date:
- 2025-07-07
- Accepted Time:
- 2025-07-07 17:31:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1211583 | Fennec Pharmaceuticals Inc. | FENC | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1185945 | A Chris Rallis | C/O Fennec Pharmaceuticals, Inc. Po Box 13628, 68 Tw Alexander Drive Research Triangle Park NC 27709 | No | No | No | No |
Transaction Summary
| Sold: | 1,119 shares | Avg. Price: $8.71 | Total Value: $9,746.49 |
| Number of Shares After Transactions: | 54,792 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2025-07-07 | 2,127 | $2.35 | 55,911 | No | 4 | M | Direct | |
| Common Shares | Disposition | 2025-07-07 | 1,119 | $8.71 | 54,792 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Options | Common Shares | Disposition | 2025-07-07 | 2,127 | $2.35 | 2,127 | $2.35 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 178,406 | 2015-08-03 | 2025-08-03 | No | 4 | M | Direct |
Footnotes
- Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on August 17, 2023.
- Shares sold to satisfy tax obligation on option exercise.
- Represents options exercised pursuant to a 10b5-1 plan adopted on August 17, 2023.
Billionaire Hedge Funds
